Effectiveness and safety of adalimumab biosimilar in inflammatory bowel disease: A multicenter study
2019; Springer Science+Business Media; Volume: 38; Issue: 1 Linguagem: Inglês
10.1007/s12664-018-0922-1
ISSN0975-0711
AutoresNagesh Kamat, Saurabh Kedia, Uday C. Ghoshal, Abhimanyu Nehra, Govind Makharia, Ajit Sood, Vandana Midha, Varun Gupta, Gourdas Choudhuri, Vineet Ahuja,
Tópico(s)Biosimilars and Bioanalytical Methods
Referência(s)